Catalyst Wire Dossier Catalyst Wire Dossier

Zavesca

Miglustat · Actelion
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Zavesca, covering 2008-02-25 to 2026-07-09. Get the full timeline:

Most recent: EMA Authorised: Zavesca (miglustat) — Advanz Pharma Limited

See pricing